Dabomb Protein (6578) - Total Assets
Based on the latest financial reports, Dabomb Protein (6578) holds total assets worth NT$1.10 Billion TWD (≈ $34.52 Million USD) as of December 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Dabomb Protein - Total Assets Trend (2015–2025)
This chart illustrates how Dabomb Protein's total assets have evolved over time, based on quarterly financial data. Also see 6578 stock market capitalisation for the company's overall valuation and market capitalisation.
Dabomb Protein - Asset Composition Analysis
Current Asset Composition (December 2025)
Dabomb Protein's total assets of NT$1.10 Billion consist of 20.6% current assets and 79.4% non-current assets. Review Dabomb Protein debt and liabilities to assess the company's total debt and financial obligations.
| Asset Category | Amount (TWD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | NT$0.00 | 12.1% |
| Accounts Receivable | NT$39.97 Million | 3.7% |
| Inventory | NT$19.05 Million | 1.7% |
| Property, Plant & Equipment | NT$0.00 | 0.0% |
| Intangible Assets | NT$0.00 | 0.0% |
| Goodwill | NT$0.00 | 0.0% |
Asset Composition Trend (2015–2025)
This chart illustrates how Dabomb Protein's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. See Dabomb Protein share price for real-time trading data and today's change.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Dabomb Protein's current assets represent 20.6% of total assets in 2025, a decrease from 77.3% in 2015.
- Cash Position: Cash and equivalents constituted 12.1% of total assets in 2025, down from 63.2% in 2015.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2015.
- Asset Diversification: The largest asset category is accounts receivable at 3.7% of total assets.
Dabomb Protein Competitors by Total Assets
Key competitors of Dabomb Protein based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Grupo Bimbo S.A.B. de C.V
MX:BIMBOA
|
Mexico | MX$414.57 Billion |
|
Britannia Industries Limited
NSE:BRITANNIA
|
India | Rs97.32 Billion |
|
Tingyi (Cayman Islands) Holding Corp
F:TYG
|
Germany | €54.94 Billion |
|
Saputo Inc
TO:SAP
|
Canada | CA$13.61 Billion |
|
ORKLA ADR/1 NK 625
F:OKL0
|
Germany | €88.70 Billion |
|
Guangdong Haid Group Co Ltd
SHE:002311
|
China | CN¥55.29 Billion |
|
Qianhe Condiment&Food Co Ltd
SHG:603027
|
China | CN¥4.46 Billion |
|
Aryzta AG
SW:ARYN
|
Switzerland | CHF1.89 Billion |
Dabomb Protein - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 2.67 | 3.66 | 1.70 |
| Quick Ratio | 2.45 | 3.46 | 1.50 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | NT$141.19 Million | NT$475.19 Million | NT$190.52 Million |
Dabomb Protein - Advanced Valuation Insights
This section examines the relationship between Dabomb Protein's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.23 |
| Latest Market Cap to Assets Ratio | 0.04 |
| Asset Growth Rate (YoY) | -16.7% |
| Total Assets | NT$1.10 Billion |
| Market Capitalization | $38.53 Million USD |
Valuation Analysis
Below Book Valuation: The market values Dabomb Protein's assets below their book value (0.04x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Dabomb Protein's assets decreased by 16.7% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Dabomb Protein (2015–2025)
The table below shows the annual total assets of Dabomb Protein from 2015 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | NT$1.10 Billion ≈ $34.52 Million |
-16.69% |
| 2024-12-31 | NT$1.32 Billion ≈ $41.44 Million |
-6.18% |
| 2023-12-31 | NT$1.40 Billion ≈ $44.17 Million |
+9.52% |
| 2022-12-31 | NT$1.28 Billion ≈ $40.33 Million |
-4.22% |
| 2021-12-31 | NT$1.34 Billion ≈ $42.11 Million |
+26.42% |
| 2020-12-31 | NT$1.06 Billion ≈ $33.31 Million |
+14.99% |
| 2019-12-31 | NT$919.35 Million ≈ $28.96 Million |
+9.20% |
| 2018-12-31 | NT$841.91 Million ≈ $26.52 Million |
-1.07% |
| 2017-12-31 | NT$851.06 Million ≈ $26.81 Million |
+3.80% |
| 2016-12-31 | NT$819.88 Million ≈ $25.83 Million |
+12.32% |
| 2015-12-31 | NT$729.95 Million ≈ $23.00 Million |
-- |
About Dabomb Protein
DaBomb Protein Biotech Corp. manufactures and sells hydrolyzed soy protein in Vietnam, the Philippines, South Korea, Taiwan, and Asia. It offers plant protein, including DaBomb-P (Aqua) and DaBomb-P (Livestock); antibiotics alternatives, such as DBT-100 HT and DBT-100 LS; and pet care products comprising Liqui-TIDE bandages. The company was formerly known as DaBomb Protein Corp. and changed its n… Read more